ADC Digest – August 2020 ADC Digest – August 2020 AstraZeneca in collaboration with Daiichi Sankyo initiated a Phase 3 study evaluating trastuzumab deruxtecan versus chemotherapy in HER2-low, HR+ breast cancer 20 Aug 2020 Enhertu (Trastuzumab deruxtecan, DNA topoisomerase I […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id